We are live on ! Find out more
GBIO

Generation Bio

Delisted

GBIO was delisted on the 6th of February, 2026.

75 hedge funds and large institutions have $136M invested in Generation Bio in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 22 increasing their positions, 28 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.06% less ownership

Funds ownership: 8.34%8.28% (-0.06%)

3% less funds holding

Funds holding: 7775 (-2)

13% less capital invested

Capital invested by funds: $156M → $136M (-$20M)

21% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 28

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

Holders
75
Holders Change
-2
Holders Change %
-2.6%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
5
Increased
22
Reduced
28
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AG
76
Artal Group
Luxembourg
-$7.98M -283,059 Closed
Wellington Management Group
77
Wellington Management Group
Massachusetts
-$337K -11,936 Closed
Millennium Management
78
Millennium Management
New York
-$276K -9,795 Closed
Citadel Advisors
79
Citadel Advisors
Florida
-$140K -4,948 Closed
CSS
80
Cubist Systematic Strategies
Connecticut
-$53.7K -1,905 Closed
SPA
81
Sherbrooke Park Advisers
New York
-$31.5K -1,116 Closed
Simplex Trading
82
Simplex Trading
Illinois
-$450 -17 Closed
CAL
83
Capital Advisors Ltd
Ohio
-$26 -1 -25%
Carson Wealth (CWM LLC)
84
Carson Wealth (CWM LLC)
Nebraska
+$53 +2 +67%

GBIO Hedge Fund Activity: Q3 2024 in Review

75 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in Generation Bio (GBIO) for Q3 2024, worth a combined $136M — down 13% from $156M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of GBIO and 5 opened new positions — a net loss of 2 holders — while 28 trimmed existing stakes and 22 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $1.95M. The largest seller was Artal Group, exiting entirely with an estimated $7.98M sold.

  • 75 institutional investors held Generation Bio (GBIO) as of Q3 2024, down from 77 in Q2 2024.
  • Funds reported $136M of Generation Bio stock for Q3 2024, down 13% quarter-over-quarter.
  • 5 funds opened new Generation Bio positions in Q3 2024 and 7 closed out, a net change of -2 holders.
  • The largest Generation Bio buyer in Q3 2024 was Baker Bros. Advisors, an estimated $1.95M added.
  • The largest Generation Bio seller in Q3 2024 was Artal Group, an estimated $7.98M sold.

Based on aggregated 13F filings for Q3 2024.